Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avid Bioservices, Inc.

12.49
+0.0000
Volume:- -
Turnover:38.32M
Market Cap:798.90M
PE:-5.22
High:12.49
Open:12.49
Low:12.49
Close:12.49
Loading ...

Avid Bioservices Inc - Transaction Expected to Close in Q1 2025 Pending Approval

THOMSON REUTERS
·
30 Dec 2024

Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by Gho and Ampersand

THOMSON REUTERS
·
30 Dec 2024

Press Release: Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand

Dow Jones
·
30 Dec 2024

Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025

GlobeNewswire
·
20 Dec 2024

IMUNON Announces Positive CMC Meeting with FDA for IMNN-001 in Treatment of Advanced Ovarian Cancer

GlobeNewswire
·
19 Dec 2024

Lifecore selected by Nirsum Laboratories to provide CDMO services

TIPRANKS
·
19 Dec 2024

Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment

GlobeNewswire
·
19 Dec 2024

BRIEF-Avid Bioservices Recommends Stockholders Vote For Value Maximizing Transaction

Reuters
·
19 Dec 2024

Avid Bioservices Inc: Special Meeting to Vote on Transaction Scheduled for Jan 30, 2025

THOMSON REUTERS
·
19 Dec 2024

Avid Bioservices Recommends Stockholders Vote for Value Maximizing Transaction

THOMSON REUTERS
·
19 Dec 2024

Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction

GlobeNewswire
·
19 Dec 2024

Novo Holdings Completes Acquisition of Catalent

Business Wire
·
18 Dec 2024

Polyrizon Collaborating With Eurofins CDMO for Clinical Trial of Allergy Blocker; Shares Jump

MT Newswires Live
·
18 Dec 2024

Polyrizon's Moving Forward with Expected 2025 Clinical Trial - Entered Manufacturing Agreement for its PL-14 Allergy Blocker

GlobeNewswire
·
18 Dec 2024

Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc.

PR Newswire
·
16 Dec 2024

Lonza Group Unveils Strategic Shift in CDMO Operations

TIPRANKS
·
12 Dec 2024

Avid Bioservices: Fiscal Q2 Earnings Snapshot

Associated Press Finance
·
11 Dec 2024

Avid Bioservices Inc reports results for the quarter ended October 31 - Earnings Summary

Reuters
·
11 Dec 2024

Avid Bioservices Q2 EPS $(0.27) Misses $(0.12) Estimate, Sales $33.50M Miss $33.80M Estimate

Benzinga
·
11 Dec 2024

Avid Bioservices Inc: Will Not Host an Earnings Conference Call and Is Suspending Its Practice of Providing Financial Guidance.

THOMSON REUTERS
·
11 Dec 2024